Ursodeoxycholic Acid Alone Is Effective and Safe to Treat Cholestatic Checkpoint Inhibitor‐Induced Liver Injury
Liver International · 2025
DOI: 10.1111/liv.70073 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Liver International, 2025. Verfasst von Lina Hountondji und 5 weiteren Autor:innen. Beteiligte Einrichtung: Hepatology and Liver Transplantation Unit, Saint Eloi Hospital, Montpellier University Hospital, Montpellier, France. Hauptthemen laut MEDLINE: Ursodeoxycholic Acid, Immune Checkpoint Inhibitors, Chemical and Drug Induced Liver Injury, Cholestasis. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Introduction
Checkpoint Inhibitor‐induced Liver Injury (CHILI) is a frequent complication of immune checkpoint inhibitors (ICIs). Corticosteroids are the standard treatment but have many limitations. Ursodeoxycholic acid (UDCA) offers an alternative for managing cholestatic CHILI, but its efficacy remains underexplored.
Methods
A multicenter retrospective study included 27 patients treated with first‐line UDCA monotherapy. Data were collected from diagnosis to week 52, assessing liver enzyme improvement, recurrence, and outcomes.
Results
UDCA alone achieved improvement in 81.5% of patients, with an average response time of 39.3 days. Among patients, 77.8% had severe CHILI (CTCAE grade ≥ 3). Macroscopic bile duct injury was observed in 37%, associated with higher recurrence rates (75%, p < 0.001). Recurrent CHILI led to chronic CHILI in all cases. ICI rechallenge was conducted in 52% of patients, with only 23% experiencing relapse.
Conclusion
UDCA monotherapy appears effective for cholestatic CHILI, presenting a viable alternative to corticosteroids. Further prospective studies are warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hepatology and Liver Transplantation Unit, Saint Eloi Hospital, Montpellier University Hospital, Montpellier, France.
- University of Montpellier, Montpellier, France.
- Medical Pharmacology and Toxicology, Lapeyronie Hospital, Montpellier University Hospital, Montpellier, France.
- Internal Medicine and Immuno Oncology (MedI2O), Montpellier University Hospital, Montpellier, France.
- Institute for Regenerative Medicine and Biotherapy (IRMB), Saint Eloi Hospital, Montpellier University Hospital, Montpellier, France.
- REFHEPS, Montpellier, France.
ORCID-Profile: Lina Hountondji, Georges-Philippe Pageaux, Lucy Meunier
Zitieren
APA
Hountondji, L., Faure, S., Palassin, P., Pageaux, G. P., Maria, A. T. J., & Meunier, L. (2025). Ursodeoxycholic Acid Alone Is Effective and Safe to Treat Cholestatic Checkpoint Inhibitor‐Induced Liver Injury. Liver International. https://doi.org/10.1111/liv.70073
Vancouver
Hountondji L, Faure S, Palassin P, Pageaux GP, Maria ATJ, Meunier L. Ursodeoxycholic Acid Alone Is Effective and Safe to Treat Cholestatic Checkpoint Inhibitor‐Induced Liver Injury. Liver International. 2025. doi:10.1111/liv.70073
BibTeX
@article{Hountondji2025,
author = {Hountondji, Lina and Faure, Stéphanie and Palassin, Pascale and Pageaux, Georges-Philippe and Maria, Alexandre Thibault Jacques and Meunier, Lucy},
title = {Ursodeoxycholic Acid Alone Is Effective and Safe to Treat Cholestatic Checkpoint Inhibitor‐Induced Liver Injury},
journal = {Liver International},
year = {2025},
doi = {10.1111/liv.70073}
}
EUVIMED